PhRMA trying to water down White House drug pricing orders

The White House is finalizing executive orders on drug pricing and is expected to release them this week.

PhRMA and its members are mobilizing to head-off or dilute plans for administrative steps that would seek to link U.S. drug prices to international prices, authorize widespread drug importation, and require that 340B hospitals provide EpiPens and insulin at no charge. The industry supports one element that is under consideration, mandating that consumers receive rebates paid for Part D drugs...